2026-04-14T19:28:49Zhttps://uvadoc.uva.es/oai/request

oai:uvadoc.uva.es:10324/40992021-09-13T09:18:01Zcom_10324_1181com_10324_931com_10324_894col_10324_1387

Arranz Sanz, Eduardo Garrote Adrados, José Antonio 2013-12-13T08:58:47Z 2013-12-13T08:58:47Z 2010 Gut, March 2010, vol.59, n.3. p.286-287 0017-5749 http://uvadoc.uva.es/handle/10324/4099 10.1136/gut.2009.189332 286 3 287 Gut 59 Producción Científica These results open the way for alternative therapies for Coeliac Disease based on the use of antioxidants, TGt inhibitors (and PPARg modulators), or the re-induction of tolerance. Competing interests None. application/pdf eng group.bml.com info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ group.bmj.com Attribution-NonCommercial-NoDerivatives 4.0 International Enfermedad celíaca - Inmunología Novel mechanisms of gliadin immunotoxicity info:eu-repo/semantics/article http://gut.bmj.com/cgi/reprintform SI